Effect of Drug Targeting Nebulization on Lung Deposition

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01877304

Enrollment

Registered

2013-06-13

Start date

2010-06-30

Completion date

2013-03-31

Last updated

2013-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Subjects

Brief summary

To compare deposition between two modalities of nebulization

Interventions

DEVICEAKITA

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

MALE

Age

18 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* Free of respiratory disease

Exclusion criteria

* Smokers

Design outcomes

Primary

Measure	Time frame
Lung deposition by scintigraphy	After 15 minutes

Secondary

Measure	Time frame
Regional deposition by scintigraphy	After 15 minutes

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026